AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
Bridge City Capital, LLC 22,659$1,042,0870.53%
SHARIAPORTFOLIO, INC. 12,505$5750.46%
FEDERATED HERMES, INC. 3,442,234$158,308,3420.42%
Hillsdale Investment Management Inc. 96,548$4,440,2420.41%
JUNCTURE WEALTH STRATEGIES, LLC 17,711$814,5290.40%
TUCKER ASSET MANAGEMENT LLC 28,950$1,331,4110.36%
FULLER & THALER ASSET MANAGEMENT, INC. 1,275,214$58,647,0690.34%
Jackson Creek Investment Advisors LLC 16,620$7640.32%
Virtus Fund Advisers, LLC 981$45,1160.32%
Yorktown Management & Research Co Inc 5,700$262,1430.30%
External links

This page lists AMPHASTAR PHARMACEUTICALS IN's shareholders in Q3 2023. To view AMPHASTAR PHARMACEUTICALS IN's shareholder history, click here.